PTGS2 and neoplasm: CA significantly inhibited the level of COX-2 activity at a dose of 40 mg/kg (p ≤ 0.05) and completely (100%) in ascites macrophages and in tumor cells at dose of 80 mg/kg (p ≤ 0.001).